Literature DB >> 14986082

Clinico-pathological findings in diarrhoea-negative haemolytic uraemic syndrome.

C M Taylor1, C Chua, A J Howie, R A Risdon.   

Abstract

This is a retrospective, national clinico-pathological study of past and current patients with haemolytic uraemic syndrome not associated with diarrhoea (D- HUS). Thirty-four patients were analysed and notified by members of the British Association for Paediatric Nephrology in 1998-1999. There was a 2:1 excess of males. Ten presented in infancy. The aetiology included 5 patients with complement abnormalities, 2 patients with complications of pneumococcal infection, and 2 with malignancies. Parental consanguinity was noted in 6 patients. Five children died, 9 developed chronic renal failure, and 10 end-stage renal failure. Only 7 made full recoveries. With a single exception, the pathological findings were unlike the previously reported glomerular thrombosis that is characteristic of diarrhoea-associated HUS, or HUS complicating verocytotoxin-producing Escherichia coli infection. Early and late glomerulopathy could be distinguished. Arteriolar and arterial disease was observed in 8 and 7 patients, respectively. Arterial disease correlated with a poor outcome. The pathology of D- HUS is of prognostic value, but this study was not powered to identify specific aetiological/pathological correlations.

Entities:  

Mesh:

Year:  2004        PMID: 14986082     DOI: 10.1007/s00467-003-1385-9

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  11 in total

1.  Renal histopathology in fatal cases of diarrhoea-associated haemolytic uraemic syndrome. British Association for Paediatric Nephrology.

Authors:  C D Inward; A J Howie; M M Fitzpatrick; F Rafaat; D V Milford; C M Taylor
Journal:  Pediatr Nephrol       Date:  1997-10       Impact factor: 3.714

2.  Thrombotic microangiopathic haemolytic anaemia (thrombotic microangiopathy).

Authors:  W S SYMMERS
Journal:  Br Med J       Date:  1952-10-25

3.  Endotheliotropic (hemolytic) nephroangiopathy and its various manifestation forms (thrombotic microangiopathy, primary malignant nephrosclerosis, hemolytic-uremic syndrome).

Authors:  W Thoenes; H D John
Journal:  Klin Wochenschr       Date:  1980-02-15

4.  The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections.

Authors:  S E Richardson; M A Karmali; L E Becker; C R Smith
Journal:  Hum Pathol       Date:  1988-09       Impact factor: 3.466

5.  Haemolytic uraemic syndromes in the British Isles 1985-8: association with verocytotoxin producing Escherichia coli. Part 1: Clinical and epidemiological aspects.

Authors:  D V Milford; C M Taylor; B Guttridge; S M Hall; B Rowe; H Kleanthous
Journal:  Arch Dis Child       Date:  1990-07       Impact factor: 3.791

6.  Familial relapsing haemolytic uraemic syndrome and complement factor H deficiency.

Authors:  P Warwicker; R L Donne; J A Goodship; T H Goodship; A J Howie; D S Kumararatne; R A Thompson; C M Taylor
Journal:  Nephrol Dial Transplant       Date:  1999-05       Impact factor: 5.992

7.  Glomerular prolapse as precursor of one type of segmental sclerosing lesions.

Authors:  A J Howie; M A Ferreira; A Majumdar; G W Lipkin
Journal:  J Pathol       Date:  2000-03       Impact factor: 7.996

8.  von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.

Authors:  M Furlan; R Robles; M Galbusera; G Remuzzi; P A Kyrle; B Brenner; M Krause; I Scharrer; V Aumann; U Mittler; M Solenthaler; B Lämmle
Journal:  N Engl J Med       Date:  1998-11-26       Impact factor: 91.245

9.  The late histologic findings in diarrhea-associated hemolytic uremic syndrome.

Authors:  N E Moghal; M A Ferreira; A J Howie; D V Milford; E Raafat; C M Taylor
Journal:  J Pediatr       Date:  1998-08       Impact factor: 4.406

10.  Cancer associated haemolytic uraemic syndrome developing prior to treatment with cytotoxic agents.

Authors:  D V Milford; A Goldstein; M Barrett; J R Mann; F Raafat
Journal:  Med Pediatr Oncol       Date:  1993
View more
  20 in total

1.  Report of an NIH task force on research priorities in chronic kidney disease in children.

Authors:  Russell W Chesney; Eileen Brewer; Marva Moxey-Mims; Sandra Watkins; Susan L Furth; William E Harmon; Richard N Fine; Ronald J Portman; Bradley A Warady; Isidro B Salusky; Craig B Langman; Debbie Gipson; Peter Scheidt; Harold Feldman; Frederick J Kaskel; Norman J Siegel
Journal:  Pediatr Nephrol       Date:  2005-10-27       Impact factor: 3.714

2.  Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome.

Authors:  Jessica Caprioli; Marina Noris; Simona Brioschi; Gaia Pianetti; Federica Castelletti; Paola Bettinaglio; Caterina Mele; Elena Bresin; Linda Cassis; Sara Gamba; Francesca Porrati; Sara Bucchioni; Giuseppe Monteferrante; Celia J Fang; M K Liszewski; David Kavanagh; John P Atkinson; Giuseppe Remuzzi
Journal:  Blood       Date:  2006-04-18       Impact factor: 22.113

3.  Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype.

Authors:  Elena Bresin; Erica Rurali; Jessica Caprioli; Pilar Sanchez-Corral; Veronique Fremeaux-Bacchi; Santiago Rodriguez de Cordoba; Sheila Pinto; Timothy H J Goodship; Marta Alberti; David Ribes; Elisabetta Valoti; Giuseppe Remuzzi; Marina Noris
Journal:  J Am Soc Nephrol       Date:  2013-02-21       Impact factor: 10.121

4.  Hemoconcentration: a major risk factor for neurological involvement in hemolytic uremic syndrome.

Authors:  Gianluigi Ardissino; Valeria Daccò; Sara Testa; Cristina Felice Civitillo; Francesca Tel; Ilaria Possenti; Mirco Belingheri; Pierangela Castorina; Nicolò Bolsa-Ghiringhelli; Silvana Tedeschi; Fabio Paglialonga; Stefania Salardi; Dario Consonni; Elena Zoia; Patrizia Salice; Giovanna Chidini
Journal:  Pediatr Nephrol       Date:  2014-08-23       Impact factor: 3.714

5.  Atypical haemolytic-uraemic syndrome due to heterozygous mutations of CFH/CFHR1-3 and complement factor H 479.

Authors:  Preeti Chaudhary; Mehmet Hepgur; Sarmen Sarkissian; Richard J H Smith; Ilene C Weitz
Journal:  Blood Transfus       Date:  2013-11-15       Impact factor: 3.443

6.  Modeling how CD46 deficiency predisposes to atypical hemolytic uremic syndrome.

Authors:  M Kathryn Liszewski; Marilyn K Leung; Barbara Schraml; Timothy H J Goodship; John P Atkinson
Journal:  Mol Immunol       Date:  2006-10-05       Impact factor: 4.407

Review 7.  Renal transplantation in HUS patients with disorders of complement regulation.

Authors:  Lothar Bernd Zimmerhackl; Johanna Scheiring; Friederike Prüfer; C Mark Taylor; Chantal Loirat
Journal:  Pediatr Nephrol       Date:  2006-10-21       Impact factor: 3.714

Review 8.  The kidney in thrombotic thrombocytopenic purpura.

Authors:  H-M Tsai
Journal:  Minerva Med       Date:  2007-12       Impact factor: 4.806

9.  Comprehensive analysis of glomerular mRNA expression of pro- and antithrombotic genes in atypical haemolytic-uremic syndrome (aHUS).

Authors:  Friedrich Modde; Putri Andina Agustian; Juliane Wittig; Maximilian Ernst Dämmrich; Vinzent Forstmeier; Udo Vester; Thurid Ahlenstiel; Kerstin Froede; Ulrich Budde; Anne-Margret Wingen; Anke Schwarz; Svjetlana Lovric; Jan Thomas Kielstein; Carsten Bergmann; Nadine Bachmann; Mato Nagel; Hans Heinrich Kreipe; Verena Bröcker; Clemens Luitpold Bockmeyer; Jan Ulrich Becker
Journal:  Virchows Arch       Date:  2013-03-09       Impact factor: 4.064

Review 10.  Translational mini-review series on complement factor H: therapies of renal diseases associated with complement factor H abnormalities: atypical haemolytic uraemic syndrome and membranoproliferative glomerulonephritis.

Authors:  M Noris; G Remuzzi
Journal:  Clin Exp Immunol       Date:  2007-12-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.